Helpharma
Helpharma is a Colombian private healthcare services company operating as an IPS, providing integrated pharmaceutical dispensing, monitored medication administration, home delivery, and multidisciplinary chronic-disease care programs across 24 locations, serving patients primarily through partnerships with SURA EPS and Compensar EPS.
- Company typePrivate
- Founded2011
- HeadquartersBogotá, Colombia
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Helpharma does
Helpharma is a privately held Colombian healthcare services company operating as an IPS (Institución Prestadora de Servicios de Salud), founded around 2011 and headquartered in Medellín. The company provides integrated pharmaceutical and clinical services for chronic disease patients across Colombia through a network of 24 locations — including 6 IPS facilities with dispensary and medication application rooms and 17 owned pharmacies — spanning Medellín, Bogotá, Barranquilla, Manizales, Cali, Rionegro, Pereira, and Armenia. Its operations are organized around four core service lines: Gestor Farmacéutico (pharmaceutical dispensing and clinical risk management), Servicio de Aplicación Monitorizada (monitored administration of biological and specialized therapies), Medicamentos a Domicilio (home medication delivery with online tracking), and Programas de Atención Integral (multidisciplinary chronic disease care programs covering immunoarthropathies, respiratory diseases, immunological disorders, osteoporosis, orphan diseases, cancer adjuvant therapies, and RSV prophylaxis).
The business is structured around partnerships with Colombian health insurance companies (EPS), with SURA EPS and Compensar EPS named as core channel partners. Each EPS integration is operationally deep: Helpharma runs dedicated patient portals for home delivery (medicamentos.helpharma.com for SURA, intranet.helpharma.com for Compensar) and an integrated appointment scheduling system supporting 50+ medication types. The combined scale is approximately 100,000-115,000 monthly dispensations and 8,000 monthly medication applications (70% in-facility, 30% home-based), with reported operational metrics including a 97% global service experience rating, sub-10-minute wait times at dispensing facilities, and sub-48-hour application scheduling. The company holds ISO 13485 certification for medical device quality management.
Helpharma's underlying technology stack consists of a TuViCare/Zentria-branded patient portal, a centralized intranet appointment scheduling system, dedicated EPS delivery portals, call-center infrastructure, and WhatsApp business channels segmented by therapy type. Patient engagement runs through the +helPharma website, a call center, WhatsApp, and the blog NotiHelPharma. The company is sales-led, employing 501-1,000 staff across Colombia, operates without disclosed external funding, and is independently held with no parent company or institutional investors identified in source material.
Helpharma firmographics
Firmographics- Name
- Helpharma
- Legal name
- Helpharma
- Website
- https://helpharma.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Helpharma is a Colombian private healthcare services company operating as an IPS, providing integrated pharmaceutical dispensing, monitored medication administration, home delivery, and multidisciplinary chronic-disease care programs across 24 locations, serving patients primarily through partnerships with SURA EPS and Compensar EPS.
- Ownership category
- akta.pro rank
Where Helpharma is headquartered
LocationHeadquarters
- HQ city
- Bogotá
- HQ country
- Colombia
- HQ region
- Latin America
Offices8 records
Markets served
Helpharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Dispensing Services: Dispensación oportuna de medicamentos y acompañamiento de los pacientes para mejorar adherencia, identificar y gestionar riesgos farmacológicos y clínicos. Approximately 100,000-115,000 monthly dispensations with 45% home delivery rate.
- Monitored Medication Application Services: Application of biological therapies and specialized medications both at facilities and at home. Approximately 8,000 applications per month with 70% in-facility and 30% home-based.
- Comprehensive Health Programs: Integral multidisciplinary care programs for chronic diseases including immunoarthropathies, respiratory diseases, and immunological disorders.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Helpharma product offering
Product offeringCore offering
Helpharma is a Colombian healthcare services provider (IPS) that delivers integrated pharmaceutical and clinical management for chronic disease patients. Its core offerings combine medication dispensing under the Gestor Farmacéutico program, monitored application of biological and specialized therapies, home delivery of medications, and multidisciplinary comprehensive care programs for immunoarthropathies, respiratory, and immunological disorders, contracted primarily through Colombian health insurance partners (EPS).
Product overview
Helpharma is a pharmaceutical and medical services company operating as an integrated platform with four interconnected core services: Gestor Farmacéutico (pharmaceutical dispensing and clinical risk management with 100,000+ monthly dispensations), Servicio de Aplicación Monitorizada (monitored medication administration with ~8,000 monthly applications at facilities or homes), Medicamentos a Domicilio (home delivery), and Programas de Atención Integral (multidisciplinary chronic disease programs). The +helPharma ecosystem is supported by a Patient Portal (TuViCare/Zentria) and an online Appointment Scheduling System. The company operates 24 national locations including 6 IPS facilities with dispensing and application services plus 17 pharmacies, serving EPS patients primarily through SURA and Compensar.
Differentiator
Problem solved
Functional benefit
Products and services
- Gestor Farmacéutico (Pharmaceutical Manager) Pharmaceutical management service focused on timely medication dispensing and patient accompaniment to improve treatment adherence, and to identify and manage pharmacological and clinical risks for high-cost chronic disease patients; processes approximately 100,000–115,000 monthly dispensations.
- Servicio de Aplicación Monitorizada de Medicamentos (Monitored Medication Application Service) Ambulatory medication injection service provided by trained health personnel at Helpharma facilities and at patients' homes, performing approximately 8,000 monthly applications (around 70% in-facility and 30% home-based); covers biological therapies, immunoglobulins, and other specialized high-cost treatments for chronic disease patients.
- Medicamentos a Domicilio (Home Medication Delivery) Home delivery service for prescribed medications enabling patients to receive prescriptions at their preferred location, eliminating pharmacy visits and offering online tracking of order status; integrated with EPS partner portals such as medicamentos.helpharma.com (SURA EPS) and intranet.helpharma.com/domicilios/compensar (Compensar EPS).
- Programas de Atención Integral en Salud (Comprehensive Health Attention Programs) Comprehensive multidisciplinary care programs for chronic disease patients covering immunoarthropathies and skin diseases, respiratory conditions (asthma, COPD), immunological disorders, and allergology; uses integrated clinical-pharmaceutical management with demonstrated success rates greater than 92% in immunomediated conditions.
- Portal del Paciente (Patient Portal – TuViCare/Zentria) Online patient portal (TuViCare/Zentria) that allows patients to check the status of pending medication, manage application appointments, and access health records related to their Helpharma-prescribed therapies.
- Sistema de Citas de Aplicación (Application Appointment System) Web-based self-service scheduling system for medication application appointments, integrated with SURA EPS and Compensar EPS systems and supporting 50+ medication types; accepts submissions from patients and caregivers for biological therapies and other specialized treatments.
Quantifiable outcome
- 97% global service experience rating
- +5 more outcomes
Companies that use Helpharma
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles2 records
Helpharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Helpharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SURA EPScoreSURA EPS is a major Colombian health insurance company (EPS) that partners with Helpharma for medication dispensing and home delivery services. Helpharma provides medication home delivery services specifically for SURA EPS patients through a dedicated portal.
Scale indicators11 records
Recent moves6 records
Expansion highlights5 records
Helpharma competitors and assessment
Company assessmentDirect peers
- Cruz Verde: One of Colombia's largest retail pharmacy chains, with broad dispensing and home-delivery capabilities; comparable in retail-pharmacy scale and EPS-contracted dispensing operations.
- Mckenzie Colombia: Specialty pharmaceutical distributor in Colombia focused on high-cost and orphan therapies; comparable in handling complex biologics and serving chronic-disease patients.
- Farmatodo: Major Colombian pharmacy chain with home-delivery, digital channels, and growing specialty services; competes directly with Helpharma on dispensing convenience and chronic-disease patient reach.
- Droguerías Colsubsidio: Affiliated pharmacy network serving a major Colombian caja compensadora; offers dispensing and patient services to a defined population, comparable to Helpharma's payer-channeled model.
- Audifarma: Colombian specialty pharmacy and chronic-disease patient management provider operating IPS infrastructure and home-delivery dispensing, directly comparable to Helpharma's Gestor Farmacéutico and monitored application model.
Broad incumbents
- EPS Sanitas: Colombian health insurance (EPS) operator with vertically integrated provider networks; comparable as both potential channel partner and competitor to Helpharma's payer-aligned service model.
- Salud Total EPS: Colombian EPS that contracts with provider networks including pharmacy and IPS services; comparable as a payer-side counterparty in Helpharma's distribution channel ecosystem.
Emerging players
- BioRx: US specialty infusion and high-touch pharmaceutical services provider; comparable as a business-model analog for monitored specialty medication administration at home and at facilities.
Regional players
- Inkafarma: Peruvian pharmacy chain with national footprint, home delivery, and chronic-disease offerings; comparable as a Latin American specialty/retail pharmacy operator, useful for cross-border benchmarking.
- Promedios IPS: Colombian ambulatory IPS focused on specialty home-based care and chronic-disease management, conceptually similar to Helpharma's monitored medication application and integral care programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Helpharma social profiles
Digital presenceHelpharma compliance and trust
Trust signalCompliance1 record
Helpharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Helpharma leadership team
Management profileNumber of profiles
Helpharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Helpharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Helpharma
What does Helpharma do?
Helpharma is a Colombian healthcare services provider (IPS) that delivers integrated pharmaceutical and clinical management for chronic disease patients. Its core offerings combine medication dispensing under the Gestor Farmacéutico program, monitored application of biological and specialized therapies, home delivery of medications, and multidisciplinary comprehensive care programs for immunoarthropathies, respiratory, and immunological disorders, contracted primarily through Colombian health insurance partners (EPS).
Is Helpharma a public or private company?
Helpharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Helpharma founded?
Helpharma was founded in 2011. It employs 501 to 1,000 people.
Where is Helpharma based?
Helpharma is headquartered in Bogotá, Colombia, in the Latin America region.
How does Helpharma make money?
Three revenue lines are on record. Pharmaceutical Dispensing Services are the primary driver. The others are monitored Medication Application Services and comprehensive Health Programs.
Who are Helpharma's main competitors?
Direct peers on record are Cruz Verde, Mckenzie Colombia, Farmatodo, Droguerías Colsubsidio and Audifarma. Broad incumbents are EPS Sanitas and Salud Total EPS. BioRx is listed as an emerging player. Regional players are Inkafarma and Promedios IPS.
Does Helpharma have an API?
No public API is recorded for Helpharma.